Niki Gavrielatou

14PUBLICATIONS
68CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 03, 2026
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC).

James Monkman, Aaron Kilgallon, Clara Lawler

|Feb 26, 2025
UVC-Induced Oxidative Stress and DNA Damage Repair Status in Head and Neck Squamous Cell Carcinoma Patients with Different Responses to Nivolumab Therapy.

Christina Papanikolaou, Panagiota Economopoulou, Niki Gavrielatou

|Jun 10, 2024
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC).

Myrto K Moutafi, Katherine M Bates, Thazin Nwe Aung

|Jun 05, 2024
Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma.

Thazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla

|Dec 23, 2023
Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.

Taja Lozar, Wei Wang, Niki Gavrielatou

|Oct 14, 2023
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond.

Taja Lozar, Israa Laklouk, Athena E Golfinos

Pageof 3

Frequent Collaborators

11 joint publications

David L Rimm

6 joint publications

Thazin Nwe Aung

4 joint publications

Panagiota Economopoulou

4 joint publications

Ioannis Vathiotis